Back to top

Image: Bigstock

NextGen Virtual Visits Offers Remote Eye Care Facilities

Read MoreHide Full Article

NextGen HealthCare, Inc. recently announced Nevada Eye Physicians, a comprehensive eye care facility in the Las Vegas area, which is utilizing NextGen Enterprise with integrated telehealth capability called NextGen Virtual Visits.

This is likely to bolster NextGen’s presence in the global healthcare information technology (HCIT) space.

More About NextGen Virtual Visits

This software platform helps eye care practices provide non-urgent ophthalmology and optometry services to patients while complying with social-distancing guidelines. By deploying NextGen Virtual Visits within a few days of the stay-at-home guideline in March, Nevada Eye Physicians was able to abide by the health requirements while performing quick rechecks for refills and triaging appointments in urgent situations.

Complying with the COVID-19 guidelines set by the Centers for Disease Control and Prevention (CDC) and the American Academy of Ophthalmology in March, Nevada Eye Physicians originally treated patients in office for emergency cases only. Using NextGen Virtual Visits, the practice is now able to offer non-urgent ophthalmologic and optometry services such as wellness visits or address vision concerns for patients in a remote manner.

NextGen Healthcare made it easy for clinics to implement telehealth within their regular workflow, thereby enabling them to provide all tools required to help patients adapt to virtual visits. Incorporation of telehealth visits between office visits help accelerate care delivery and reduce patient wait times.

Recent Development

In June, NextGen announced that Capital Women’s Care, OB/GYN private practice in the mid-Atlantic region, has utilized NextGen Virtual Visits for the expansion of women’s healthcare services during the coronavirus public health emergency. This will also bolster NextGen’s presence in the global HCIT space.

Market Prospects

The virtual healthcare market is expected to reach a worth of more than $3.5 billion by 2022, with a CAGR of 49.8% during the forecast period, according to a recent report by Verify Markets.

Price Performance

Over the past year, shares of this company have lost 45.1% against the industry’s growth of 1.7%.

Zacks Rank and Key Picks

NextGen currently has a Zacks Rank #3 (Hold).

Some better-ranked stocks from the broader medical space are Laboratory Corporation of America Holdings (LH - Free Report) , Surmodics (SRDX - Free Report)  and Quest Diagnostics (DGX - Free Report) .

LabCorp’s long-term earnings growth rate is estimated at 6.1%. The company presently carries a Zacks Rank #2 (Buy). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.

Surmodics’ long-term earnings growth rate is estimated at 10%. The company presently carries a Zacks Rank #2.

Quest Diagnostics’ long-term earnings growth rate is estimated at 7.6%. It currently carries a Zacks Rank #1.

Biggest Tech Breakthrough in a Generation

Be among the early investors in the new type of device that experts say could impact society as much as the discovery of electricity. Current technology will soon be outdated and replaced by these new devices. In the process, it’s expected to create 22 million jobs and generate $12.3 trillion in activity.

A select few stocks could skyrocket the most as rollout accelerates for this new tech. Early investors could see gains similar to buying Microsoft in the 1990s. Zacks’ just-released special report reveals 8 stocks to watch. The report is only available for a limited time.

See 8 breakthrough stocks now>>.


Unique Zacks Analysis of Your Chosen Ticker


Pick one free report - opportunity may be withdrawn at any time


Labcorp (LH) - $25 value - yours FREE >>

Quest Diagnostics Incorporated (DGX) - $25 value - yours FREE >>

Surmodics, Inc. (SRDX) - $25 value - yours FREE >>

Published in